Kidney paired donation and optimizing the use of live donor organs

JAMA

Volumn 293, Issue 15, 2005, Pages 1883-1890

  Segev, Dorry L ^a   Gentry, Sommer E ^b   Warren, Daniel S ^a   Reeb, Brigitte ^a   Montgomery, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BLOOD GROUP TYPING; COST BENEFIT ANALYSIS; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HLA MATCHING; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; RECIPIENT; SIMULATION; ECONOMICS; HISTOCOMPATIBILITY TEST; HUMAN; METHODOLOGY; TRANSPLANTATION;

ALGORITHMS; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; TISSUE AND ORGAN PROCUREMENT;

EID: 17144414075     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.15.1883     Document Type: Article

References (30)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl Med. 1999;341:1725-1730.
2. UNOS organ procurement and transplantation network data. United Network for Organ Sharing Web site. Available at http://www.unos.org/. Accessed Sept 17, 2004.
3. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation. 2000;70:887-895.
4. Montgomery RA, Cooper M, Kraus E, et al. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl. 2003:199-213.
5. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4:1033-1041.
6. Jordan SC, Vo AA, Nast CC, Tyan D. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience. Clin Transpl. 2003:193-198.
7. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant. 2004;4:1315-1322.
8. Stegall MD, Dean PG, Cloor JM. ABO-incompatible kidney transplantation. Transplantation. 2004;78:635-640.
9. Warren DS, Zachary AA, Sonnenday O, et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant. 2004;4:561-568.
10. Zachary AA, Montgomery RA, Ratner LE, et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation. 2003;76:1519-1525.
11. Ross LF, Rubin DT, Siegler M, et al. Ethics of a pairedkidney-exchange program. N Engl J Med. 1997;336:1752-1755.
12. Delmonico FL, Morrissey PE, Lipkowitz GS, et al. Donor kidney exchanges. Am J Transplant. 2004;4:1628-1634.
13. UNOS. Concept Proposal for a National Live Donor Paired Kidney Exchange Program through the Organ Procurement & Transplantation Network/United Network for Organ Sharing. Presented August 20, 2004, for consideration by the UNOS Board.
14. Leffell MS, Steinberg AG, Bias WB, et al. The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. Transplantation. 1994;58:1119-1130.
15. Zenios SA. Optimal control of a paired-kidney exchange program. Manage Sci. 2002;48:328-342.
16. Zenios SA, Woodle ES, Ross LF. Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange. Transplantation. 2001;72:648-654.
17. Edmonds J. Paths, trees, and flowers. Can J Math. 1965;17:449.
18. Lovász L, Plummer MD. Matching Theory. New York, NY: Elsevier; 1986:369-375.
19. Doxiadis II, Smits JM, Schreuder GM, et al. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet. 1996;348:850-853.
20. Doxiadis II, Smits JM, Stobbe I, et al. Taboo HLA mismatches in cadaveric renal transplantation. Transplant Proc. 1996;28:224.
21. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. Hum Immunol. 2002;63:339-352.
22. Thompson JS, Thacker L, Byrne J. Prospective trial of a predictive algorithm to transplant cadaver kidneys into highly sensitized patients. Transplantation. 2002;73:1274-1280.
23. Opelz G. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation. 1997;64:1473-1475.
24. Gjertson DW, Terasaki PI, Takemoto S, Mickey MR. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med. 1991;324:1032-1036.
25. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med. 2000;343:1078-1084.
26. Martin S, Connolly J, Jos V. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. Transplant Proc. 1993;25:265-266.
27. United States Renal Data System Annual Data Report 2003. Available at: http://www.usrds.org /adr_2003.htm. Accessed March 24, 2005.
28. Ross LF, Woodle ES. Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs. Transplantation. 2000;69:1539-1543.
29. Roth AE, Sönmez T, Ünver MU. Kidney exchange. Q J Economics. May 2004:457-488.
30. Montgomery RA. ABO incompatible transplantation. Am J Transplant. 2004;4:1011-1012.